HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 127 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,132,000 | -38.1% | 127,706 | -11.8% | 0.00% | – |
Q2 2022 | $1,829,000 | -31.5% | 144,781 | +2.6% | 0.00% | -100.0% |
Q1 2022 | $2,671,000 | -45.0% | 141,157 | +1.9% | 0.00% | 0.0% |
Q4 2021 | $4,860,000 | -4.3% | 138,554 | -0.1% | 0.00% | 0.0% |
Q3 2021 | $5,080,000 | -3.3% | 138,751 | +3.7% | 0.00% | 0.0% |
Q2 2021 | $5,256,000 | +27.6% | 133,820 | -8.3% | 0.00% | 0.0% |
Q1 2021 | $4,120,000 | +1.7% | 145,853 | +15.2% | 0.00% | 0.0% |
Q4 2020 | $4,053,000 | +1.7% | 126,586 | +2.6% | 0.00% | 0.0% |
Q3 2020 | $3,984,000 | +17.1% | 123,347 | -0.0% | 0.00% | 0.0% |
Q2 2020 | $3,403,000 | +107.9% | 123,362 | +34.6% | 0.00% | 0.0% |
Q1 2020 | $1,637,000 | -27.6% | 91,649 | +1.7% | 0.00% | 0.0% |
Q4 2019 | $2,260,000 | +39.5% | 90,138 | -0.7% | 0.00% | – |
Q3 2019 | $1,620,000 | -14.2% | 90,781 | +5.8% | 0.00% | -100.0% |
Q2 2019 | $1,888,000 | -17.2% | 85,797 | +15.1% | 0.00% | 0.0% |
Q1 2019 | $2,279,000 | +51.0% | 74,529 | +14.1% | 0.00% | – |
Q4 2018 | $1,509,000 | – | 65,330 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Karst Peak Capital Ltd | 225,000 | $5,195,000 | 19.07% |
AIA Investment Management Private Ltd | 354,035 | $8,175,000 | 3.37% |
Bellevue Group AG | 440,169 | $10,164,000 | 0.67% |
Prince Street Capital Management LLC | 81,400 | $1,879,000 | 0.46% |
PRUDENTIAL PLC | 4,112,412 | $94,956,000 | 0.38% |
OppenheimerFunds, Inc. | 4,265,943 | $98,501,000 | 0.14% |
Fullerton Fund Management Co Ltd. | 9,941 | $230,000 | 0.13% |
SECTORAL ASSET MANAGEMENT INC | 31,628 | $730,000 | 0.10% |
SCHRODER INVESTMENT MANAGEMENT GROUP | 1,803,955 | $41,653,000 | 0.08% |
Sands Capital Management | 830,520 | $19,177,000 | 0.07% |